214 related articles for article (PubMed ID: 35610648)
21. Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.
Zhou Y; Bian B; Yuan X; Xie G; Ma Y; Shen L
PLoS One; 2015; 10(6):e0130873. PubMed ID: 26098665
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
[TBL] [Abstract][Full Text] [Related]
23. Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis.
Huang C; Lin X; He J; Liu N
Gynecol Oncol; 2021 May; 161(2):613-620. PubMed ID: 33674144
[TBL] [Abstract][Full Text] [Related]
24. The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy?
Bogush TA; Basharina AA; Bogush EA; Scherbakov AM; Davydov MM; Kosorukov VS
Ir J Med Sci; 2022 Oct; 191(5):2047-2053. PubMed ID: 34741718
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer.
Ciucci A; Zannoni GF; Travaglia D; Petrillo M; Scambia G; Gallo D
Gynecol Oncol; 2014 Feb; 132(2):351-9. PubMed ID: 24378878
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis.
Li J; Li S; Chen R; Yu H; Lu X
J Ovarian Res; 2015 Aug; 8():54. PubMed ID: 26242216
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis.
Lu Y; Li L
Technol Cancer Res Treat; 2021; 20():15330338211043784. PubMed ID: 34817271
[No Abstract] [Full Text] [Related]
29. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis.
Sun S; Cai J; Yang Q; Zhu Y; Zhao S; Wang Z
PLoS One; 2016; 11(11):e0166058. PubMed ID: 27812204
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and toxicity of angiogenesis inhibitors for ovarian cancer: a meta-analysis of randomized controlled trials.
Guo C; Yan C; Qu L; Du R; Lin J
Arch Gynecol Obstet; 2021 Feb; 303(2):285-311. PubMed ID: 33222040
[TBL] [Abstract][Full Text] [Related]
33. Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies.
Ide H; Inoue S; Miyamoto H
PLoS One; 2017; 12(3):e0174746. PubMed ID: 28362839
[TBL] [Abstract][Full Text] [Related]
34. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
Yang Z; Gu JH; Guo CS; Li XH; Yang WC
Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
[TBL] [Abstract][Full Text] [Related]
35. Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer.
De Stefano I; Zannoni GF; Prisco MG; Fagotti A; Tortorella L; Vizzielli G; Mencaglia L; Scambia G; Gallo D
Gynecol Oncol; 2011 Sep; 122(3):573-9. PubMed ID: 21665249
[TBL] [Abstract][Full Text] [Related]
36. Expression of oestrogen receptor β and prognosis of colorectal cancer.
Rudolph A; Toth C; Hoffmeister M; Roth W; Herpel E; Jansen L; Marx A; Brenner H; Chang-Claude J
Br J Cancer; 2012 Aug; 107(5):831-9. PubMed ID: 22828608
[TBL] [Abstract][Full Text] [Related]
37. [Expressions of estrogen receptor subtypes in epithelial ovarian carcinomas].
Han LP; Dong ZM; Qiao YH; Nesland JM; Suo ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):606-10. PubMed ID: 16909613
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis.
Piao J; Lim HJ; Lee M
Obstet Gynecol Sci; 2020 May; 63(3):346-356. PubMed ID: 32489980
[TBL] [Abstract][Full Text] [Related]
39. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.
Suzuki F; Akahira J; Miura I; Suzuki T; Ito K; Hayashi S; Sasano H; Yaegashi N
Cancer Sci; 2008 Dec; 99(12):2365-72. PubMed ID: 19032364
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of estrogen receptor beta is a prognostic marker in non-small cell lung cancer: a meta-analysis.
Luo Z; Wu R; Jiang Y; Qiu Z; Chen W; Li W
Int J Clin Exp Med; 2015; 8(6):8686-97. PubMed ID: 26309520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]